SIGA
SIGAFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade F from latest DB weights. Momentum 3.8 / Value 60.0
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
4
Value
60
Sentiment
N/A
Setup hits (3d)
— · Net —
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net —
Target $11.48
Why
Momentum4 · Δ7d -4.0
Value60 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Weak posture. Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
4
40% active weight
Current posture
7d trendSoftening
Δ7d
-4.0
Δ21d
-10.0
Value
60
60% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 3.8 / Value 60.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$246.73M
Beta
0.96
Shares Out
71.72M
P/E (TTM)
6.2
P/S (TTM)
2.66
P/FCF (TTM)
3.94
Rev YoY
-11.3%
EPS YoY
+745.6%
Gross Margin
+65.4%
Op Margin
+52.4%
Net Debt
-$154.17M
Current Ratio
3.25
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology